Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2026-02-26 @ 11:05 AM
Study NCT ID:
NCT05418803
Status:
COMPLETED
Last Update Posted:
2022-06-16
First Post:
2022-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BE Study of Two Formulations of Rivaroxaban 2.5 mg in Healthy Subjects
Sponsor:
Yuhan Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
YHP1807-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None